glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Nervous System Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayer, R; Chen, W; Hasegawa, Y; Kanamaru, K; Sozen, T; Sugawara, T; Suzuki, H; Taki, W; Zhang, JH | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Nervous System Diseases
| Article | Year |
|---|---|
Effects of recombinant osteopontin on blood-brain barrier disruption after subarachnoid hemorrhage in rats.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Chi-Square Distribution; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; I-kappa B Kinase; Male; MAP Kinase Kinase 4; Matrix Metalloproteinase 9; Nervous System Diseases; Neurologic Examination; Oligopeptides; Osteopontin; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Severity of Illness Index; Subarachnoid Hemorrhage | 2011 |